Providing stock analysis for investors of the Canadian junior markets
Australia has become the first country in the world to re-classify the psychedelic substances psilocybin and MDMA (3,4-methylenedioxy-methamphetamine) as medicines.
Read more
Last week, Quebec became the first governing medical body in Canada to publicly fund medical psilocybin-assisted psychotherapy, with advocates hoping
Read more
Revive Therapeutics (CSE: RVV) this morning provided a corporate update as it pertains to its psychedelic assets. The update primarily
Read more
Compass Pathways (NASDAQ: CMPS) this morning provided a brief update to the market on the latest status of its ongoing
Read more
Numinus Wellness (TSXV: NUMI) is undertaking further studies of its psilocybin products. The company this morning announced a partnership with
Read more
Revive Therapeutics (CSE: RVV) this morning announced that it has successfully completed research on an oral thin film delivery system
Read more
Revive Therapeutics (CSE: RVV) this morning announced that it has entered into a letter of intent to acquire PharmaTher Inc’s
Read more
For our final episode of The Daily Dive this week, host Cassandra Leah is joined by that of Derek Welsh
Read more
Revive Therapeutics (CSE: RVV) has completed its oral thin film strip product for psilocybin after several months of prototyping. The
Read more
Psychedelics are a class of pharmacological compounds that produce unique and profound changes of consciousness. The most common psychedelics are
Read more